eli lilly tirzepatide shortage US FDA says Lilly's weight-loss drug is resolved Lilly CEO says weight-loss drug
Description
Mounjaro is not for use in people with type 1 diabetes
Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects
Ive run weight loss programmes tackling healthy behaviour changes in the workplace and online, in groups or one-to-one
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.
Find the right weight loss path for you.
Get a free consultation for medically supervised weight loss today!
